Burning questions remain on Trump drug price executive order
Daniel Payne and Ed Silverman , 2025-05-12 20:51:00 WASHINGTON — President Trump’s executive order to lower drug prices through sweeping, cross-agency action left leaders in the pharmaceutical industry scrambling Monday to make sense of what may be ahead — and how to respond. The announcement was long on messaging, but short on details. That may…